Study Finds Niacin Is Better Than Zetia At Reducing Artery Clogs

A new study published in the New England Journal of Medicine finds that Niacin (produced by Abbott and sold as Niaspan) is more effective than the new blockbuster drug ezetimibe (produced by Merck and sold as Zetia) at reducing artery-clogging deposits caused by high...

Drug giants unite to develop cancer therapy

Merck and AstraZeneca, two giant drug houses have announced plans to collaborate on a cancer drug therapy.  They are both working on drugs that block a cancer's pathway to growth but when one way is blocked, the cancer may take another pathway.  This collaboration...

Medical Madoff: Data Faked in 21 Studies

"Over the past 12 years, anesthesiologist Scott Reuben revolutionized the way physicians provide pain relief to patients undergoing orthopedic surgery for everything from torn ligaments to worn-out hips. Now, the...

Merck and Schering-Plough in $41 Billion Merger

Pharmaceutical giant Merck, known for its Gardasil product, is acquiring Schering-Plough in a $41 billion dollar merger. The overall goal is to compete more closely with Pfizer, which is the largetst pharma...

Merck approves use of its HPV vaccine Gardasil in males

Human papillomavirus, or HPV, is an oncogenic virus implicated in causing nearly 100% of all cervical cancer cases, but it does not just target females. It also infects males, and can cause anal, penile, neck...

Brazil to produce generic AIDS drug

" © AP 2008-09-18 03:43:04 - BRASILIA, Brazil (AP) - Brazil's health minister says Latin America's biggest country will produce an inexpensive generic version of an AIDS drug made by Merck & Co. Jose...

Weekly Radio Spin -- Merck's Having Chest Pains

Listen to this week's edition of the "Weekly Radio Spin," the Center for Media and Democracy's audio report on the stories behind the news. This week, we look at how Barbie celebrates Earth Day, why Freedom's...

Weekly Radio Spin -- It Pays to Be Duby-ous

This week, we look at why leaders in China -- and the U.S. -- think more propaganda is better, what happens when journalists wear a PR hat too, and who's joining Blackwater's crowded payroll. In "Six Degrees of...

Merck tells AIDS vaccine volunteers who got jab

"WASHINGTON (Reuters) - Thousands of people who volunteered to test an experimental AIDS vaccine that may have actually raised the risk of infection will be told if they got the actual shot, researchers said on Tuesday. Merck & Co. Inc. and academic researchers said they...

Breaking: Merck Agrees to Pay $4.85 Billion for Vioxx Claims

Merck Agrees to Pay $4.85 Billion for Vioxx ClaimsThree years after withdrawing its pain medication Vioxx from the market, Merck announced today that it will pay $4.85 billion to settle 27,000 lawsuits by people...

The Politics and PR of Cervical Cancer

The Center for Media and Democracy has completed a four part series of articles, The Politics and PR of Cervical Cancer, about the first FDA approved human papillomavirus (HPV) vaccine GARDASIL,...

Mylan completes acquisition of generics business of Merck KGaA

"Robert J. Coury, Mylan's Vice Chairman and Chief Executive Officer said, "The new Mylan now has all of the critical attributes we need to ensure future success and deliver powerful growth. We have enhanced scale and stability, a truly global reach, vertical and horizontal...

HIV Vaccine Fails - Another Clinical Trial on Horizon?

A new HIV vaccine, supported by WHO and UNAIDS, being pushed by Merck hit a roadblock this week.  The STEP program, which has participants in North America, Australia, South America, and the Caribbean, has,...

Vioxx Ruling Eases Threat to Merck

"September 7, 2007 DOW JONES REPRINTS This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order...

closeSign in to NowPublic

is reporting from